What’s the current market cap for Usana Health Sciences stock?

Usana Health Sciences (USNA) has a market cap of $335m as of June 05, 2026.

What is the P/E ratio for Usana Health Sciences stock?

The price to earnings (P/E) ratio for Usana Health Sciences (USNA) stock is 37.54 as of June 05, 2026.

Does Usana Health Sciences stock pay dividends?

No, Usana Health Sciences (USNA) stock does not pay dividends to its shareholders as of June 05, 2026.

When is the next Usana Health Sciences dividend payment date?

Usana Health Sciences (USNA) stock does not pay dividends to its shareholders.

What is the beta indicator for Usana Health Sciences?

Usana Health Sciences (USNA) has a beta rating of 0.77. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy Usana Health Sciences stock | $USNA Share Price

13:30

15:10

16:45

18:25

20:00

About Usana Health Sciences

Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).

Ticker

$USNA

Sector

Consumer Essentials

Primary listing

NYSE

Employees

1,570

Headquarters

Salt Lake City, United States

Website

www.usana.com

USNA Metrics

BasicAdvanced

$335m

37.54

$0.48

0.77

What the Analysts think about USNA

Analyst ratings (Buy, Hold, Sell) for Usana Health Sciences stock.

Bulls say / Bears say

Rise Wellness generated strong momentum with sales tripling year-over-year and expanded into large club retailers, setting the stage for accelerated net sales growth in FY2026 (Business Wire)

Non-core segments, including Hiya and Rise Wellness, comprised 16% of consolidated net sales in FY2025, up from approximately 1% in FY2024, and are projected to exceed 20% in FY2026, enhancing revenue diversification (Business Wire)

Consolidated net sales rose 8% year-over-year to $925.3 million in FY2025, with sequential Q4 2025 net sales up 6%, indicating stabilization across key markets including mainland China and North America (Business Wire)

Core nutritional net sales declined 8% year-over-year to $780 million in FY2025 and are forecast to further decrease by 0–5% in FY2026, underscoring continued weakness in the legacy direct-selling channel (Business Wire)

Net earnings plunged 74% to $10.8 million in FY2025, adjusted diluted EPS fell 25% to $1.93, and adjusted EBITDA declined 8% to $101.3 million, reflecting margin pressure and hefty one-time charges (Business Wire)

Greater China net sales fell 11% year-over-year to $100 million in Q4 2025 with active customers down 15%, highlighting outsized exposure and risk in USANA’s largest market (Business Wire)

Data summarised monthly by Lightyear AI. Last updated on 4 Jun 2026.

USNA Financial Performance

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37bn

-39.75%

Net income

$45bn

107.52%

Profit margin

37.65%

6.78%

USNA Earnings Performance

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $USNA

Capital at risk

Market closed

Upcoming events

No upcoming events

Bulls say / Bears say

Rise Wellness generated strong momentum with sales tripling year-over-year and expanded into large club retailers, setting the stage for accelerated net sales growth in FY2026 (Business Wire)

Greater China net sales fell 11% year-over-year to $100 million in Q4 2025 with active customers down 15%, highlighting outsized exposure and risk in USANA’s largest market (Business Wire)

Data summarised monthly by Lightyear AI. Last updated on 4 Jun 2026.